TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06944925: A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

Sponsor: Bambusa Therapeutics · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 286 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$993,344

Rescue Site Savings

+$654,704

Unlock Full NCT06944925 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06944925 Rescue Dossier →